The Chris Wolfe Podcast:Your AMD Technology Isn’t the Problem—Your System Is

Age-Related Macular Degeneration: From Detection to Implementation

Age-related macular degeneration (AMD) management has changed dramatically. We have better imaging, better monitoring, more treatment options, and a deeper understanding of risk than ever before.

But having more technology doesn’t automatically translate into better patient care.

In this episode, Dr. Chris Wolfe takes a different approach to AMD. Rather than starting with the newest device, supplement, or treatment, he starts with a more important question:

What happens after you identify a patient with AMD or meaningful AMD risk?

The challenge for many practices isn’t a lack of knowledge or technology—it’s building a reliable system that connects what we know with what actually happens to the patient.

Chris discusses how AMD classification should drive management, where AREDS2 supplementation fits, how testing such as OCT, dark adaptometry, ERG, carotenoid testing, and remote monitoring can be incorporated intentionally, and where newer treatment options such as photobiomodulation may fit into the AMD management pathway.

Most importantly, he discusses why the comprehensive examination should be the entry point—not the endpoint—of AMD care.

In This Episode

You’ll hear about:

Understanding AMD as a spectrum of disease rather than a single diagnosis

Using AMD classification to determine risk and next steps